3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Malabsorption Syndromes: new trials by email Literature Review of Malabsorption Syndromes trials Research Report on Malabsorption Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) Cohort 1 in Part A, Cohort 2 in Part A, Placebo: Group 1 in Part B and Part C - Celiac Disease | Phase 1 / Phase 2 | Terminated | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 128 | 2022-11-15 | 2026-03-10 |
| Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration Simvastatin - Celiac Disease | Phase 1 | Terminated | University of Zurich | 12 | 2012-07-01 | 2015-06-03 |
| Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome | Phase 1 / Phase 2 | Terminated | Alberta Children's Hospital | 13 | 2012-01-01 | 2014-12-23 |
Celiac Disease (2) · Enterocolitis, Necrotizing (1) · Gastroschisis (1) · Infant Nutrition Disorders (1) · Intestinal Atresia (1) · Intestinal Failure (1) · Malnutrition (1) · Short Bowel Syndrome (1)
Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Nutritional and Metabolic Diseases (3) · Metabolic Diseases (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Abnormalities (1) · Enterocolitis (1) · Gastroenteritis (1) · Hernia (1) · Hernia, Abdominal (1) · Musculoskeletal Abnormalities (1) · Musculoskeletal Diseases (1)
Glucagon-Like Peptide 2 (1) · Simvastatin (1)
Alberta Children's Hospital (1) · Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA (1) · University of Zurich (1)
Australia (1) · Canada (1) · New Zealand (1) · Switzerland (1) · United States (1)
David Sigalet, MD PhD (1) · Gerhard Rogler, Prof MD PhD (1)